4-22387826-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The ENST00000334304.10(ADGRA3):c.3845G>A(p.Gly1282Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1282A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000334304.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRA3 | NM_145290.4 | c.3845G>A | p.Gly1282Asp | missense_variant | 19/19 | ENST00000334304.10 | NP_660333.2 | |
ADGRA3 | XM_047449703.1 | c.3254G>A | p.Gly1085Asp | missense_variant | 19/19 | XP_047305659.1 | ||
ADGRA3 | XM_047449704.1 | c.3254G>A | p.Gly1085Asp | missense_variant | 19/19 | XP_047305660.1 | ||
ADGRA3 | XM_011513811.3 | c.3167G>A | p.Gly1056Asp | missense_variant | 14/14 | XP_011512113.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRA3 | ENST00000334304.10 | c.3845G>A | p.Gly1282Asp | missense_variant | 19/19 | 1 | NM_145290.4 | ENSP00000334952 | P1 | |
ADGRA3 | ENST00000282943.9 | n.3416G>A | non_coding_transcript_exon_variant | 17/17 | 1 | |||||
ADGRA3 | ENST00000499527.6 | n.3542G>A | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
ADGRA3 | ENST00000511051.5 | c.104+1262G>A | intron_variant, NMD_transcript_variant | 3 | ENSP00000424927 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251296Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135812
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461830Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727210
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has not been reported in the literature in individuals affected with ADGRA3-related conditions. This variant is present in population databases (rs149299752, gnomAD 0.01%). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 1282 of the ADGRA3 protein (p.Gly1282Asp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at